Recalls for 12/14/2013

Alexion Provides Update on Previously Communicated November 2013 Voluntary Nationwide Recall of Two Lots of Soliris (eculizumab) Concentrated Solution for Intravenous Infusion
12/14/2013 Food Recall

December 13, 2013 - Cheshire, Conn., – Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today is providing further information regarding a previously communicated voluntary recall of two lots of Soliris (eculizumab) Concentrated Solution for Intravenous Infusion. As stated on Nov. 12, 2013, the two lots were found to contain visible particles.

  • Company:
    Alexion Pharmaceuticals, Inc.